There appears to be no slowing down for Natera Inc. (NTRA), with the diagnostics company once again revising up its revenue outlook for 2025.
The company offers cell-free DNA testing, with a focus on oncology, women's health, and organ health.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com